- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05493527
Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Neonates
Noninvasive High Frequency Oscillatory Ventilation as a Post-extubation Respiratory Support in Preterm Neonates: A Randomized Controlled Trial
Study Overview
Status
Detailed Description
The use of noninvasive respiratory support (NRS) has increased in recent decades in Neonatal Intensive Care Unit (NICU) as a means to reduce ventilator-induced lung injury. Various modes of NRS are available and in common use. However despite extensive research, the optimal modality of noninvasive modes remain unknown.
Noninvasive high-frequency oscillatory ventilation (NHFOV) is a relatively new mode. It consists of the application of a continuous distending positive pressure with superimposed oscillations. It is a method of augmenting Continuous positive airway pressure (CPAP) support potentially combining the advantages of both high-frequency oscillatory ventilation and CPAP.
The new NHFOV technique offers improved carbon dioxide (CO2) removal and increased functional residual capacity. The superimposed oscillations of NHFOV are thought to help avoid gas trapping and upregulate mean airway pressure.
This technique is also characterized by lower tidal volume resulting in fewer barotraumas /volutraumas and not needing synchronization. NHFOV was considered a strengthened version of CPAP.
The hypothesis is that NHFOV might be superior to NIPPV as a post-extubation respiratory support strategy to avoid reintubation and subsequent complications and/or sequelae in preterm infants.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sondos Ahmed
- Phone Number: 202 0109440704
- Email: sondosahmedsalah@gmail.com
Study Locations
-
-
Abbasia
-
Cairo, Abbasia, Egypt, 11517
- Recruiting
- Neonatal Intensive Care Units (NICUs), Ain Shams University
-
Contact:
- Sondos Ahmed
- Phone Number: 202 01094407204
- Email: sondosahmed@med.asu.edu.eg
-
Contact:
- Email: sondosahmedsalah@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Preterm neonates with gestational age ≤ 35 weeks.
- Neonates that were on invasive mechanical ventilation for at least 48 hours eligible for extubation
Exclusion Criteria:
- Patients with major upper or lower airway anomalies.
- Patients with significant congenital anomalies including cardiac, abdominal or respiratory.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: noninvasive high frequency oscillatory ventilation (NHFOV)
After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NHFOV as post extubation noninvasive respiratory support
|
A time-cycled, pressure-limited, and continuous-flow neonatal ventilator (SLE6000; SLE) was used for neonates assigned to the NHFOV group. The settings were as follows:
|
|
Active Comparator: noninvasive positive pressure ventilation (NIPPV)
After documenting parental consent, the ventilated infants eligible for extubation were randomly assigned to NIPPV as post extubation noninvasive respiratory support
|
NIPPV will be delivered by ventilator generating the targeted pressures. Infants will be on:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Re-intubation rate
Time Frame: 72 hours
|
Percentage of Patients who failed weaning on the assigned noninvasive mode and needed reintubation to the total number of patients assigned to that mode.
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days on the assigned non-invasive respiratory support
Time Frame: 8 weeks or till patient discharge which comes first
|
To document number of days on the assigned non-invasive respiratory support
|
8 weeks or till patient discharge which comes first
|
|
Days on supplemental oxygen
Time Frame: 8 weeks or till patient discharge which comes first
|
To document number of days on supplemental oxygen
|
8 weeks or till patient discharge which comes first
|
|
Duration of admission
Time Frame: 8 weeks or till patient discharge which comes first
|
To document total number of days of admission
|
8 weeks or till patient discharge which comes first
|
|
Mortality rate
Time Frame: 8 weeks or till patient death which comes first
|
To document incidence of mortality during hospitalization
|
8 weeks or till patient death which comes first
|
|
Lung ultrasound score
Time Frame: Before extubation and after 2 hours on assigned mode
|
lung ultrasound was performed to all patients before extubation and 2 hours after extubation to assess lung aeration.
Score ranges from 0 to 18 .Higher score indicates worse lung aeration.
|
Before extubation and after 2 hours on assigned mode
|
|
Co2 change
Time Frame: Before extubation and after 2 hours on assigned mode
|
Co2 change in patients on assigned mode using venous blood gases performed before extubation and 2 hours after.
|
Before extubation and after 2 hours on assigned mode
|
|
Oxygen requirement
Time Frame: Before extubation and after 2 hours on assigned mode
|
Fraction of inspired oxygen required to patients on assigned mode
|
Before extubation and after 2 hours on assigned mode
|
|
Incidence of feeding intolerance
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
|
Percentage of Patients who developed feeding intolerance on the assigned noninvasive mode to the total number of patients assigned to that mode.
|
8 weeks or till patient weaning from assigned mode which comes first
|
|
Days to reach full intake
Time Frame: 8 weeks or till patient discharge which comes first
|
Number of days needed by each patient to reach full intake
|
8 weeks or till patient discharge which comes first
|
|
Intracranial hemorrhage
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
|
Percentage of patients developing intracranial hemorrhage on the assigned noninvasive mode to the total number of patients assigned to that mode.
|
8 weeks or till patient weaning from assigned mode which comes first
|
|
Pneumothorax
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
|
Percentage of patients developing pneumothorax on the assigned noninvasive mode to the total number of patients assigned to that mode.
|
8 weeks or till patient weaning from assigned mode which comes first
|
|
Incidence of occurrence of Nasal trauma
Time Frame: 8 weeks or till patient weaning from assigned mode which comes first
|
Percentage of patients developing nasal trauma on the assigned noninvasive mode to the total number of patients assigned to that mode.
|
8 weeks or till patient weaning from assigned mode which comes first
|
|
incidence of bronchopulmonary dysplasia
Time Frame: 8 weeks or till patient discharge which comes first
|
Need for supplemental oxygen for at least 28 days, percentage of these patients on the assigned noninvasive mode to the total number of patients assigned to that mode.
|
8 weeks or till patient discharge which comes first
|
|
Severity of respiratory distress
Time Frame: Before extubation and and after 2 hours on assigned mode
|
Assessment of work of breathing on assigned mode by Downe 's score.
Score ranges from 0 till 10 .
Higher score indicates worse work of breathing.
|
Before extubation and and after 2 hours on assigned mode
|
|
Need for Postnatal Steroids
Time Frame: 8 weeks or till patient discharge which comes first
|
Percentage of patients who needed postnatal steroids administration
|
8 weeks or till patient discharge which comes first
|
|
Chest x ray change
Time Frame: Before extubation and and after 2 hours on assigned mode
|
Chest x ray grading of RDS performed to patient before and after the assigned mode to compare lung aeration degree.
|
Before extubation and and after 2 hours on assigned mode
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MD 90/2020
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Tract Diseases
-
University of Colorado, DenverBiofireCompletedAcute Respiratory Infection | Lower Respiratory Tract Illness | Respiratory Pathogens | Upper Respiratory Tract IllnessUnited States
-
Hasanuddin UniversityNot yet recruitingRespiratory Tract Infections (RTI)
-
Huazhong University of Science and TechnologyNot yet recruitingRespiratory Tract Infections (RTI)China
-
Min-Tze LIONGXinyi City People's HospitalRecruitingRecurrent Respiratory Tract InfectionsMalaysia, China
-
Fondazione Policlinico Universitario Campus Bio-MedicoOM Pharma SAActive, not recruitingRespiratory Tract Infections (RTI)Italy
-
Bioithas SLCentro Sperimentale del Latte S.r.l.RecruitingPrevention | Upper Respiratory Tract InfectionSpain
-
Zambon SpACompleted
-
Lallemand Pharma AGNot yet recruitingHealthy Children | Respiratory Tract Infections (RTI)Poland
-
Insel Gruppe AG, University Hospital BernRecruitingMenopausal Women | Respiratory Tract Infections (RTI)Switzerland
-
PfizerTerminatedRespiratory Tract InfectionUnited States, Australia
Clinical Trials on noninvasive high frequency oscillatory ventilation
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOPD | Non-invasive VentilationChina
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingHealthy Subjects | Non-invasive VentilationChina
-
Guangzhou Institute of Respiratory DiseaseNot yet recruitingCOPD Exacerbation | Non-invasive Ventilation
-
Johns Hopkins UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedRespiratory Distress Syndrome, AdultUnited States
-
Shanghai Zhongshan HospitalRecruitingHypoxia | Critical Illness | Atelectasis, PostoperativeChina
-
Shanghai Zhongshan HospitalRecruitingAcute Respiratory Distress Syndrome | Atelectasis | VAP - Ventilator Associated PneumoniaChina
-
Ain Shams UniversityCompletedEffect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in NeonatesRespiratory Tract Diseases | Cerebral Blood Flow | Infant, Premature, DiseasesEgypt
-
Muhammad Aamir LatifCompletedRespiratory Distress SyndromePakistan
-
Kafrelsheikh UniversityCompleted
-
Canadian Critical Care Trials GroupCanadian Institutes of Health Research (CIHR); McMaster University; University...TerminatedAcute Respiratory Distress Syndrome (ARDS)Chile, Canada, United States, India, Saudi Arabia